Gene Therapy and Gene Editing in Type 1 Diabetes: CRISPR-Based β-Cell Replacement and Treg Immune Modulation Approaches.
Saved in:
| Title: | Gene Therapy and Gene Editing in Type 1 Diabetes: CRISPR-Based β-Cell Replacement and Treg Immune Modulation Approaches. |
|---|---|
| Authors: | Lin TM; Digital Transformation Research Institute, Institute for Information Industry, Taipei, Taiwan., Chang HF; Division of Endocrinology, Department of Internal Medicine, Hsinchu Mackay Memorial Hospital, Hsinchu, Taiwan., Lin TC; Division of Pharmacy, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan., Lin CH; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan., Sun YL; Animal & Plant Health and Production Research Center, Agricultural Technology Research Institute, Hsinchu, Taiwan., Lin CS; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.; Center for Intelligent Drug Systems and Smart Bio-Devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu, Taiwan. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jul; Vol. 28 (7), pp. 5476-5491. Date of Electronic Publication: 2026 Apr 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
